For relevance BD1 has 5 quarters of cash left we all know how fast medi companies burn cash on R and D and their ROE (return on equity) is almost negative permanently (9/10 years) ditto their earnings; ZNO does not need to answer the question of cash quarters because it is cash flow positive every quarter. Further their ROE fy '20 was near +80%. I'll stay the course with the profitable one thanks.
zno, page-21
Add ZNO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
-0.001(3.13%) |
Mkt cap ! $6.625M | |||
| Open | High | Low | Value | Volume |
| 3.1¢ | 3.1¢ | 2.7¢ | $51.82K | 1.816M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25444 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 17860 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.9¢ |
Change
-0.001 ( 9.38 %) |
||||
| Open | High | Low | Volume | ||
| 3.1¢ | 3.1¢ | 2.7¢ | 766743 | ||
| Last updated 15.37pm 10/05/2024 ? | |||||
| ZNO (ASX) Chart |